|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2009-5-19
|
|
pubmed:abstractText |
We performed a pilot study, looking at the COX-2 inhibitor celecoxib, on newly diagnosed prostate cancer patients in the neo-adjuvant setting using DNA microarray analysis.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1109-6535
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
6
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
93-9
|
|
pubmed:meshHeading |
pubmed-meshheading:19451093-Base Sequence,
pubmed-meshheading:19451093-Cyclooxygenase Inhibitors,
pubmed-meshheading:19451093-DNA, Complementary,
pubmed-meshheading:19451093-DNA Primers,
pubmed-meshheading:19451093-Gene Expression Profiling,
pubmed-meshheading:19451093-Humans,
pubmed-meshheading:19451093-Male,
pubmed-meshheading:19451093-Oligonucleotide Array Sequence Analysis,
pubmed-meshheading:19451093-Polymerase Chain Reaction,
pubmed-meshheading:19451093-Prostatic Neoplasms,
pubmed-meshheading:19451093-Pyrazoles,
pubmed-meshheading:19451093-Single-Blind Method,
pubmed-meshheading:19451093-Sulfonamides
|
|
pubmed:articleTitle |
A gene expression profiling approach assessing celecoxib in a randomized controlled trial in prostate cancer.
|
|
pubmed:affiliation |
Room 14AY04, Faculty of Health and Medical Sciences, University of Surrey GU2 7XH, UK.
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Clinical Trial, Phase II
|
